The week of July 20–27 arrives with no formal earnings in the payload but a dense non-earnings catalyst calendar dominated by semiconductor and AI hardware events. NVDA presents at SIGGRAPH today and the DAC chips-to-systems conference on Sunday. AMD runs its "Advancing AI 2026" event Tuesday–Wednesday. The event note flags Wednesday as the biggest earnings day — GOOGL reports after the close — while INTC prints Thursday with its turnaround story still very much in focus. Macro flow is light on G7 rate decisions but carries meaningful data: Canadian CPI lands today, UK CPI and jobs data run Tuesday–Wednesday, and ZEW sentiment surveys from Germany and the Eurozone report Tuesday. Underneath the surface, ORTEX signals are loud: INFY sits at maximum borrow stress with CTB up 160% in a week, LCID has surged 33% in a week with CTB at 229%, and a cluster of short-interest builds in biotech and materials demands attention.
Monday (today) — Canada CPI. June inflation prints at 8:30am ET. Consensus expects headline YoY at 2.9%, down from 3.2% in May. Trimmed-mean and median measures are both expected to hold at 2.0%–2.1%. A softer print would add to the case for Bank of Canada easing.
Tuesday — UK Jobs & Earnings. The Office for National Statistics releases May employment data at 7:00am London. Consensus: unemployment rate 5.0% (from 4.9%), claimant count change +28.3K (from +31.2K). Average earnings including bonuses are expected at 4.5% YoY. Wage growth above expectation keeps Bank of England pressure elevated. Also Tuesday: the ECB Bank Lending Survey drops — watch for any signal on credit tightening across the eurozone.
Tuesday — ZEW Sentiment. German ZEW economic sentiment is expected at 18 (from 10.5). The Eurozone reading is expected at 11.5 (from 9.5). Both represent meaningful improvements. A beat would reinforce the euro area recovery thesis.
Wednesday — UK CPI. June CPI prints at 7:00am London. Consensus: headline YoY 2.7% (from 2.8%), core 2.5% (from 2.6%). A downside miss would pressure sterling and increase the probability of a BoE cut by autumn.
Non-earnings catalysts this week:
The event note identifies a busy week, with the biggest prints clustering Wednesday–Thursday. No earnings snapshot data is in the payload for the companies below; figures come from the event note and open convergences.
GOOGL — Alphabet, Wednesday after close The event note calls this "the week's biggest day." AI spending, Search revenue, and Google Cloud growth are the watch points. Alphabet is the clearest bellwether for both AI capex and digital advertising demand. Options positioning on adjacent names will react to this print.
INTC — Intel, Thursday 4pm ET Intel carries an active ORTEX convergence: CTB up 136% in one week to 0.52%, SI at 2.6% of free float (falling, down 13.9% in a week), and options PCR at 0.92 against a 20-day mean of 0.97. Analyst price target: $106.70 against a Friday close of $95.04. The stock fell 13.5% last week and 18.8% over the past month. CTB rising while SI falls suggests bears are covering but borrow costs are climbing anyway — a complicated setup. The event note describes this as "a pivotal report amid its ongoing turnaround."
SCHW — Charles Schwab, Tuesday 8:30am ET The event note flags net interest income and trading volumes as the key watch points. Rate backdrop from the week's macro prints is directly relevant here.
GOOGL context via AMD event: AMD runs its "Advancing AI 2026" event Tuesday–Wednesday before Alphabet reports. AMD's commentary on AI chip demand will set the narrative entering the GOOGL print.
CHTR — Charter Communications, Friday morning Cable and broadband subscriber trends in focus. Cord-cutting and broadband pricing are the metrics to watch.
INFY — Infosys This is the loudest borrow signal of the week. CTB hit 31.9% on July 17 — up 160% in one week. Utilization: 100%. Availability collapsed to near-zero (0.048%). Short interest rose 14.4% in a week and 25.8% in a month. Options PCR fell to 2.47 — well below the 20-day mean of 3.26, a z-score of -2.69. That means put-buying has dropped sharply relative to recent norms. Four ORTEX signal types are aligned: CTB, options, short interest, and utilization. Infosys reports Q2 results this week in India. The borrow market is seized. Analyst mean target: $13.27 vs. Friday close of $11.49.
LCID — Lucid Group LCID surged 13.9% on Friday and 32.6% for the week. The stock is up 46.6% over the past month. Yet CTB hit 229.7% — up 811% in one week. Utilization: 100%. Availability: 0.0004% of short interest. SI % of free float: 20.2%. Three convergences are live: CTB, options, and utilization. The analyst mean target is $8.30 against a close of $7.36 — meaning the stock has run through recent consensus. Days-to-cover: 4.06. A stock up 47% in a month with 100% utilization and 229% CTB is a volatile setup in either direction.
KRMN — Karman Holdings Fresh critical pulse today: SI climbed 49.7% in one week to 10.2% of free float. Availability is 267% — meaning shorts are building despite ample borrow. This is an aggressive directional bet, not a technical squeeze. Worth watching.
PTCT — PTC Therapeutics Critical pulse this morning: SI surged 34.6% in one week to 20.8% of free float, the highest level in months. The stock is trading near 52-week highs. Short sellers are building into strength — a classic setup where bears expect a reversal.
SNDK — Sandisk Corporation Convergence active across CTB, options, and SI. The stock fell 29.3% last week and 32.0% in the past month. Yet SI % of free float is only 4.7% and falling (-32.4% in a week). Analyst mean target: $2,180 vs. a close of $1,354. Shorts are covering hard. CTB fell 61.6% in a week. This looks like post-print capitulation — the question is whether covering is complete.
Semiconductors: Diverging Signals into a Catalyst-Heavy Week This is the defining sector theme. NVDA ($4.9T) presents at SIGGRAPH today. AMD ($808B) runs its AI event Tuesday–Wednesday. INTC ($478B) reports Thursday. QCOM presents at DAC on Sunday. The signals diverge sharply. INTC has CTB rising 136% even as shorts cover. SNDK shorts are capitulating after a 32% monthly drawdown. NVDA and AMD are in conference mode — any AI demand commentary will ripple through the sector. The DAC (Design Automation Conference) running July 26–29 with NVDA, AMD, INTC, and MSFT all presenting makes Sunday the next major catalyst point.
Materials Under Pressure XLB — the Materials Select Sector SPDR — carries an active convergence. SI is 23.9% of free float (high). Utilization: 75.4%. CTB fell 40.8% in a week, suggesting some covering. But SI fell only 16.3% in a week — borrow is easing faster than positions are closing. The ETF is down 4.2% over the past month. Canadian CPI today (a proxy for resource demand) and ZEW German sentiment Tuesday both have relevance for materials pricing. A soft ZEW miss would add pressure.
Biotech: Scattered but Loud REPL (Replimune) has three signal types aligned — SI at 28.5% of free float (high, though falling 13% in a week), CTB rising 35.7%, and PCR at 0.71 (a 52-week high, z-score +1.83). The bear case centres on its FDA CRL history for RP1. PTCT SI surged 34.6% to 20.8%. TNGX hit 30.8% of float last week, up 31.7%. The H.C. Wainwright Ophthalmology Conference runs Wednesday, featuring BLTE and OCUL — small-cap catalysts with outsized short interest sensitivity.
Three threads dominate the week.
First: GOOGL Wednesday after close. The biggest single macro-earnings event of the week. AI capex guidance and Cloud growth will set the tone for the entire tech sector into next week. AMD's AI event Tuesday sets the narrative backdrop.
Second: INTC Thursday. Down 18.8% over the past month, CTB rising sharply, analyst target 12% above current price. The turnaround story either finds a floor here or accelerates lower.
Third: INFY borrow stress. CTB at 31.9%, utilization at 100%, availability near zero. With four convergences aligned and SI rising 26% in a month, the positioning into the Q2 print is extreme. A surprise — in either direction — has the ingredients for a violent move.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
